In the pharmaceutical industry, the overarching goal is to bring drugs and devices to market faster that improve health outcomes for patients. Once approved, additional research is needed to ensure appropriate utilization to maximize health benefits and reduce the overall cost of care. RWE provides insights into how a drug is used and how it performs in the “real world” in a broader population of patients than those included in clinical trials. Historically, RWDs were utilized in post-authorization safety only, but more recently, the use of RWD has become acceptable and sometimes necessary in regulatory evaluations.
- Information generated in routine medical practice: electronic health claims data, pharmacy data, and clinical outcomes reported by patients.
- Epidemiological data, registry data, health survey data, and data collected during observational trials and pragmatic studies.
With more than 25 years of experience in Life Sciences research, we have the knowledge and expertise to conduct robust studies that meet the needs of all stakeholders. There’s no challenge too big or too small, and we dedicate our utmost attention and energy to every project.